GlobalData analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's ...

AC Immune SA (ACIU) has released an update. AC Immune SA announced promising interim results from its Phase 2 trial of the ACI-7104.056 ...

The study was backed by the Aufzien Family Center for the Prevention and Treatment of Parkinson's Disease at TAU. The paper ...

AC Immune (ACIU) stock shot up 20% Thursday after the company reported positive data from a Phase 2 study of its drug ...

A new study that aims to understand the genetics of Parkinson’s has been held up by the need for 7000 Australians without a ...

According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not ...

Among the symptoms, losing one's sense of smell could be an easily missed early indicator. The University of Auckland ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.